Logo

Zyomyx Raises Another $10M in Equity Financing

Feb 12, 2004

NEW YORK, Feb. 12 (GenomeWeb News) - Protein array company Zyomyx has raised $10 million in additional venture capital, the company said yesterday.

 

The financing round was led by CSFB Private Equity, which was joined by existing investors Alloy Ventures, Lilly BioVentures, Hambrecht & Quist Capital Management, Mediphase Venture Partners, and Bio One Capital.

 

Zyomyx plans to use the funding to expand its line of products. The company wants to launch a murine cytokine biochip in April, followed by other biochips later this year.

 

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.